DPP-IV Inhibitory Potentials of Flavonol Glycosides Isolated from the Seeds of Lens culinaris: In Vitro and Molecular Docking Analyses

Dipeptidyl peptidase IV (DPP-IV), a new target for the treatment of type 2 diabetes mellitus, degrades incretins such as glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide. DPP-IV inhibitors shorten the inactivation of GLP-1, permitting the incretin to stimulate insulin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Bo-Ram, Kim, Hyo Young, Choi, Inhee, Kim, Jin-Baek, Jin, Chang Hyun, Han, Ah-Reum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222902/
https://www.ncbi.nlm.nih.gov/pubmed/30103438
http://dx.doi.org/10.3390/molecules23081998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222902/
https://www.ncbi.nlm.nih.gov/pubmed/30103438
http://dx.doi.org/10.3390/molecules23081998

Ejemplares similares